Trastuzumab therapy vs tetracycline controlled ERBB2 downregulation: influence on tumour development in an ERBB2-dependent mouse tumour model

por Hermes, M, Schormann, W, Brulport, M, Uhlemann, K, Lupatsch, F, Horn, L C, Schumann, A, Allgaier, C, Weishaupt, M, Engeland, K, Müller, G A, Mössner, J, Bauer, A, Schiffer, I B, Gebhard, S, Schmidt, M, Lausch, E, Prawitt, D, Wilhelm, C, Hengstler, J G
Publicado 2008